Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment
Justification for type of information:
Data is from peerreivewed journal.

Data source

Reference
Reference Type:
publication
Title:
Final Report on the Safety Assessment
Author:
Mary Ann Liehert
Year:
1984
Bibliographic source:
International Journal of Toxicology; 1984

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: As mentioned below.
Principles of method if other than guideline:
To evaluate the skin sensitizing potential of test chemical l in human by patch test.
GLP compliance:
not specified
Type of study:
patch test
Justification for non-LLNA method:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
tert-butyl-4-methoxyphenol
EC Number:
246-563-8
EC Name:
tert-butyl-4-methoxyphenol
Cas Number:
25013-16-5
Molecular formula:
C11H16O2
IUPAC Name:
(1,1-Dimethylethyl)-4-methoxyphenol
Details on test material:
Name: Butylated Hydroxyanisole
Molecular Formula: C11H16O2
Molecular Weight: 181.253 g/mole

In vivo test system

Test animals

Species:
other: Human
Strain:
other: Not applicable
Sex:
male/female
Details on test animals and environmental conditions:
No data available.

Study design: in vivo (non-LLNA)

Induction
Route:
epicutaneous, occlusive
Vehicle:
not specified
Concentration / amount:
0.2 %
Day(s)/duration:
3 weeks
Adequacy of induction:
not specified
Challenge
No.:
#1
Route:
epicutaneous, occlusive
Vehicle:
not specified
Concentration / amount:
0.2%
Day(s)/duration:
24 hour
Adequacy of challenge:
not specified
No. of animals per dose:
108 adult panelists (70 females, 38 males)
Details on study design:
RANGE FINDING TESTS:

MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 9
- Exposure period: 24 hour
- Test groups: yes
- Control group: No data available
- Site: upper arm
- Frequency of applications: every other day for continuous 3 weeks
- Duration: 3 weeks
- Concentrations: 0.2%

B. CHALLENGE EXPOSURE
- No. of exposures:Single
- Day(s) of challenge: 2 weeks
- Exposure period: 24 hour
- Test groups: Yes
- Control group: No data available
- Site: No data available
- Concentrations: 0.2%
- Evaluation (hr after challenge): 24 hour

OTHER:
Challenge controls:
No data available.
Positive control substance(s):
not specified

Study design: in vivo (LLNA)

Statistics:
No data available.

Results and discussion

In vivo (non-LLNA)

Results
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
0.2%
No. with + reactions:
0
Total no. in group:
108
Clinical observations:
No sensitization observed.
Remarks on result:
no indication of skin sensitisation

In vivo (LLNA)

Cellular proliferation data / Observations:
No sensitization observed.

Applicant's summary and conclusion

Interpretation of results:
other: Not sensitizing
Conclusions:
The test chemical at a concentration of 0.2 % was tested in 108 adult panelists by 24-hour in occlusive patch test .No sensitization observed . Hence the test chemical was considered to be non-sensitizing in any 108 panelists.
Executive summary:

A skin sensitization test was observed in 108 (70 females, 38 males) to determine their skin response to a cream containing 0.2 percent test chemical. The method used was a modification of the repeated insult patch test. A 24-hour occlusive patch to the upper arm was applied every other day for 3 weeks (nine induction applications), a 2-week rest, followed by a 24-hour occlusive challenge patch. After the challenge exposure no sensitization was observed in any subject. Therefore the test chemical was considered to be non-sensitizing to human skin.